GP Healthcare Capital Leads $28M Series B In Adagene
January 29, 2016 — 10:48 CST
This Data Is Locked!
This area is available only to Subscribers.
Suzhou-based antibody discovery and development start-up Adagene Inc. has completed a US$28 million series B financing led by GP Healthcare Capital, according to a company... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals